ProBioGen and Spica Therapeutics, a biotechnology company advancing pathogenic macrophage subset-targeted immunotherapies, ...
The renewed agreement supports Merck’s efforts to integrate AI more deeply into its scientific workflows. With ongoing access ...
Cellular Origins, a company that enables the manufacturing of cell therapies at scale, has completed a $40 million ...
Pfizer has entered into an exclusive global collaboration and license agreement with YaoPharma for the development, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback